Found: 5
Select item for more details and to access through your institution.
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00856-8
- By:
- Publication type:
- Article
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0741-6
- By:
- Publication type:
- Article
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer.
- Published in:
- SCIENCE CHINA Life Sciences, 2016, v. 59, n. 5, p. 468, doi. 10.1007/s11427-016-5023-8
- By:
- Publication type:
- Article
Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 5, p. 1601, doi. 10.3892/etm.2016.3102
- By:
- Publication type:
- Article